You are here:

Forthcoming Submission: niraparib tosylate monohydrate (Zejula)

Indication: As monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy

Drug Details

Drug Name: niraparib tosylate monohydrate (Zejula)
Drug Manufacturer: Tesaro UK Ltd
BNF Category:
Submission type: Full submission
SMC Meeting Date: TBC
Advice Due: TBC

Back